Radiofrequency Ablation Is Associated with Decreased Neoplastic Progression in Patients with Barrett's Esophagus and Confirmed Low-Grade Dysplasia

Aaron J. Small, James L. Araujo, Cadman Leggett, Aaron H. Mendelson, Anant Agarwalla, Julian A. Abrams, Charles J. Lightdale, Timothy C. Wang, Prasad G Iyer, Kenneth Ke Ning Wang, Anil K. Rustgi, Gregory G. Ginsberg, Kimberly A. Forde, Phyllis A. Gimotty, James D. Lewis, Gary W. Falk, Meenakshi Bewtra

Research output: Contribution to journalArticle

35 Scopus citations

Abstract

Background & Aims Barrett's esophagus (BE) with low-grade dysplasia (LGD) can progress to high-grade dysplasia (HGD) and esophageal adenocarcinoma (EAC). Radiofrequency ablation (RFA) has been shown to be an effective treatment for LGD in clinical trials, but its effectiveness in clinical practice is unclear. We compared the rate of progression of LGD after RFA with endoscopic surveillance alone in routine clinical practice. Methods We performed a retrospective study of patients who either underwent RFA (n = 45) or surveillance endoscopy (n = 125) for LGD, confirmed by at least 1 expert pathologist, from October 1992 through December 2013 at 3 medical centers in the United States. Cox regression analysis was used to assess the association between progression and RFA. Results Data were collected over median follow-up periods of 889 days (interquartile range, 264-1623 days) after RFA and 848 days (interquartile range, 322-2355 days) after surveillance endoscopy (P =.32). The annual rates of progression to HGD or EAC were 6.6% in the surveillance group and 0.77% in the RFA group. The risk of progression to HGD or EAC was significantly lower among patients who underwent RFA than those who underwent surveillance (adjusted hazard ratio = 0.06; 95% confidence interval: 0.008-0.48). Conclusions Among patients with BE and confirmed LGD, rates of progression to a combined end point of HGD and EAC were lower among those treated with RFA than among untreated patients. Although selection bias cannot be excluded, these findings provide additional evidence for the use of endoscopic ablation therapy for LGD.

Original languageEnglish (US)
Pages (from-to)567e3-576e3
JournalGastroenterology
Volume149
Issue number3
DOIs
StatePublished - Sep 1 2015

    Fingerprint

Keywords

  • Clinical Setting
  • Eradication
  • Esophageal Cancer
  • Prevention

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Small, A. J., Araujo, J. L., Leggett, C., Mendelson, A. H., Agarwalla, A., Abrams, J. A., Lightdale, C. J., Wang, T. C., Iyer, P. G., Wang, K. K. N., Rustgi, A. K., Ginsberg, G. G., Forde, K. A., Gimotty, P. A., Lewis, J. D., Falk, G. W., & Bewtra, M. (2015). Radiofrequency Ablation Is Associated with Decreased Neoplastic Progression in Patients with Barrett's Esophagus and Confirmed Low-Grade Dysplasia. Gastroenterology, 149(3), 567e3-576e3. https://doi.org/10.1053/j.gastro.2015.04.013